# Phase 2 exit gate — implementation authorization

**Assessment date:** 2026-08-21
**Fixed baseline:** `phase-1-experimental^{}` = `d77a8320e6751a2deb2daf14cf1ac5d6b00cb989`
**Decision:** Implementation authorization remains pending; every gate is open until explicitly closed by the program owner

This is the final gate for beginning coding changes. It is intentionally separate from the evidence register: a green build or a large findings count cannot substitute for the decisions and validation below.

| Gate | Status | Evidence or remaining requirement |
| --- | --- | --- |
| Fixed Phase 1 baseline is immutable and reproducible | Complete | Annotated tag resolves to the recorded commit; product-scope diff remains empty. |
| Quality standard, coverage, finding, recommendation, and decision structures exist | Complete | Phase 2 operating manual and templates are present and linked. |
| Calibration and assessment operating model accepted | Complete | `P2-D008` authorizes read-only full assessment. |
| All applicable coverage rows are assessed or explicitly excluded | Open | `COV-013` is excluded by `P2-D014`. `COV-009`, `COV-010`, `COV-014`, `COV-015`, `COV-017`, and `COV-019` now have representative evidence complete. `COV-001`, `COV-008`, `COV-012`, `COV-016`, and `COV-018` retain bounded structural/deployed evidence and open production or human validation. |
| Blocker, high, systemic, clinical-safety, and disputed conditions independently validated | Open | Engineering corroboration is extensive. The remaining work is qualified clinical, HIM, accessibility, privacy/policy, interoperability, pharmacy, scheduling, and operations adjudication plus the focused dynamic cases named by the findings. |
| Runtime, database, recovery, and deployment evidence is available | Open | Local Docker/PostgreSQL migration resilience, backup/restore, integration recovery, critical-result acknowledgement, FHIR, authorization, and modern-UI gates were exercised. The empty bootstrap and several broad verification gates failed. The healthy Azure demo predates the baseline and does not prove current production topology, HA, failover, alerting, or representative performance. |
| Human policy and specialist decisions are recorded | Open | All twelve target-policy defaults are approved by `P2-D016`. Independent accessibility evaluation and qualified legal/HIM, clinical, interoperability, security/privacy, and operations acceptance evidence remain required; approving the defaults did not close this gate. |
| Recommendations are ordered, measurable, and accepted | Open | Seven decision-ready recommendations and a dependency roadmap are prepared in `recommendations/README.md` and `phase-3-roadmap.md`; none is accepted. |
| Phase 3 implementation scope, owners, rollback, and acceptance evidence are approved | Open | Requires explicit recommendation acceptance, named wave/packet owners, completed specialist validation, rollback evidence, and program-owner authorization. |

## Current disposition

Phase 2 has produced a substantial, traceable evidence base: 64 canonical findings, ten assessment packets, a scorecard, a residual-coverage reconciliation, a runtime-readiness packet, seven decision-ready proposed recommendations, a specialist-validation plan, and a dependency-ordered Phase 3 roadmap. Thirty-nine findings are High and all thirty-nine are blockers against the adopted production target. The target-policy review is complete; specialist evidence, recommendation acceptance, owners, rollback, current deployment proof, and explicit gate closure remain. This is not yet sufficient to begin coding.

No application, database, deployment, test, or runtime implementation changes are authorized while these gates are open. A gate closes only on explicit program-owner instruction after its evidence is accepted or its residual risk is formally accepted in a new decision-log entry. Any residual-risk acceptance must identify the affected findings, target use, owner, expiry/review date, and compensating controls.

The [Phase 2 completion audit](phase-2-completion-audit.md) maps completed assessment/preparation obligations to evidence and identifies the gate conditions that cannot be inferred or closed by documentation.
